Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
3.576
-0.034 (-0.94%)
Oct 30, 2025, 12:46 PM EDT - Market open

Verrica Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
3463308113252298
Upgrade
Market Cap Growth
-44.25%-79.41%172.47%-55.17%-15.33%-27.31%
Upgrade
Enterprise Value
588826775216263
Upgrade
Last Close Price
3.617.0073.2027.5091.60115.10
Upgrade
PS Ratio
1.878.3860.0912.5121.01-
Upgrade
PB Ratio
--6.4315.582.827.739.03
Upgrade
P/TBV Ratio
--15.582.827.739.03
Upgrade
EV/Sales Ratio
3.9211.5752.198.3217.98-
Upgrade
Debt / Equity Ratio
-2.22-4.662.300.041.331.13
Upgrade
Asset Turnover
0.320.110.080.140.16-
Upgrade
Inventory Turnover
3.718.37----
Upgrade
Quick Ratio
1.121.604.3510.051.531.66
Upgrade
Current Ratio
1.261.764.5511.311.611.71
Upgrade
Return on Equity (ROE)
--1546.58%-224.08%-67.42%-106.97%-87.13%
Upgrade
Return on Assets (ROA)
-51.93%-59.89%-62.56%-21.32%-25.04%-35.23%
Upgrade
Return on Capital (ROIC)
-86.94%-80.21%-73.97%-22.64%-26.42%-37.10%
Upgrade
Earnings Yield
-142.53%-120.80%-21.76%-21.67%-13.92%-14.34%
Upgrade
FCF Yield
-138.89%-96.15%-12.65%-16.77%-11.29%-10.64%
Upgrade
Buyback Yield / Dilution
-63.95%-14.26%-32.72%-26.32%-8.20%-0.39%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q